GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (FRA:11L) » Definitions » Deferred Tax

Canopy Growth (FRA:11L) Deferred Tax : €-1.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Canopy Growth Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Canopy Growth's change in deferred tax for the three months ended in Dec. 2023 was €-0.7 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.0 Mil.

Canopy Growth Deferred Tax Historical Data

The historical data trend for Canopy Growth's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Deferred Tax Chart

Canopy Growth Annual Data
Trend Jul13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.72 -78.84 -8.78 -6.42 -3.26

Canopy Growth Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.93 -10.52 1.40 8.88 -0.74

Canopy Growth Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canopy Growth Deferred Tax Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth (FRA:11L) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (FRA:11L) » Definitions » Deferred Tax
Comparable Companies
XCNQ:CL TSX:GUD TSX:DHT.U TSX:TSND NEOE:GLAS.A.U XCNQ:AAWH.U TSX:ACB XCNQ:EPIC XCNQ:IAN NEOE:CBST ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
CGC:USA WEED:Canada
Address
1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Website
https://www.canopygrowth.com
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Canopy Growth (FRA:11L) Headlines

No Headlines